Accordingly, the BRAF-mutant melanoma is a p16-lost or negative tumor, where TP53 mutations are relatively rare, but this is the form where the MITF and PD-L1 (programmed death ligand 1) genes are amplified. This evidence concerns the gene MITF and neoplasm.